Skip to content

Arrowhead Research ARWR Net Change in Cash

Net Change in Cash at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$198.88M-999%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$309.88M+321%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$28.41M-66.0%
Royalty Pharma logo
Royalty PharmaRPRX
-$32.3M-120%
AbbVie logo
AbbVieABBV
$4.16B+1,293%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's net change in cash?
Arrowhead Research (ARWR) reported net change in cash of -$14.12M in Q1 2026.
How has Arrowhead Research's net change in cash changed year-over-year?
Arrowhead Research's net change in cash decreased by 110.7% year-over-year, from $132.22M to -$14.12M.
What does net change in cash mean?
The total change in the company's cash balance during the period.
How do you interpret net change in cash?
A consistent increase indicates strong cash generation or successful capital raising, while a decrease signals cash burn.
How does net change in cash compare across companies?
Crucial for biotech companies to monitor as it dictates the 'cash runway' before needing further financing.